Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72189-283

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72189-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189 283 20

72189 283 20
Label for Cyclobenzaprine HCL 5 mg film-coated tablets, 20 count, packaged and distributed by DirectRx. The label includes the NDC 72189-283-20, lot number 20JA2212, and expiration date 3/31/24. It states that each tablet contains 5 mg of Cyclobenzaprine Hydrochloride USP and is a generic for Flexeril.*
FDA Label Image

72189 283 30

72189 283 30
Packaging label for Cyclobenzaprine HCL 5 mg film-coated tablets, containing 30 tablets. The label indicates it is a generic for Flexeril, with each tablet containing 5 mg of Cyclobenzaprine Hydrochloride USP. The product is packaged and distributed by DirectRx, with manufacturing information and lot number visible.*
FDA Label Image

Shdghlk (72189 283 90)

Shdghlk (72189 283 90)
Label for CYCLOBENZAPRINE HCL 5 mg film-coated tablets, 90 count, by DirectRx. The label includes the generic name Cyclobenzaprine Hydrochloride and the product NDC 72189-283-90. It states the product is a generic for FLEXERIL and provides lot number, expiration date, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.